Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
3
天
STIM1-mediated Treg instability in HFpEF: a new immunological target emerges?
作者
Anna Planavila; Albert Blasco-Roset展开收起
作者单位
1. Departament de Bioquímica i Biomedicina Molecular, Institut de Biomedicina (IBUB), Universitat de Barcelona and CIBER Fisiopatología de la Obesidad y Nutrición, Barcelona, Spain展开收起
75
天
Effect of empagliflozin on copeptin levels in patients with recent acute coronary syndrome and newly detected dysglycaemia: a post-hoc analysis of the SOCOGAMI randomized controlled trial
作者
Elena Fortin; Olle Melander; Giulia Ferrannini; Per Näsman; Anna Norhammar; Lars Rydén; Stina Smetana; Malin Svensson; Linda Mellbin展开收起
作者单位
1. Department of Medicine K2 Solna, Karolinska Institutet, Stockholm, Sweden; 2. Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; 3. Internal Medicine Unit, Södertälje Hospital, Södertälje, Sweden; 4. Center for Safety Research, KTH Royal Institute of Technology, Stockholm, Sweden; 5. Capio St Görans Hospital, Stockholm, Sweden; 6. Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden展开收起
91
天
Association of the triglyceride-glucose index with subclinical left ventricular dysfunction in type 2 diabetes mellitus: mediation by myocardial energetic efficiency and resting perfusion
作者
Li Jiang; Yuan Li; Hua‑Yan Xu; Xue-Ming Li; Ke Shi; Jin Wang; Shi-Qin Yu; Yu Jiang; Han Fang; Wei‑Feng Yan; Ying‑Kun Guo; Zhi-Gang Yang展开收起
作者单位
1. Department of Radiology, West China Hospital, Sichuan University, Chengdu, China; 2. Department of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China展开收起
46
天
Baseline, repeated-measure burden, and two-time-point patterns of the triglyceride-glucose index-visceral lipid ratio (TyG-VLR) and incident cardiovascular disease in cardiovascular-kidney-metabolic (CKM) syndrome stages 0–3: a longitudinal China Health and Retirement Longitudinal Study (CHARLS) analysis
作者
Ao-Men Lu; Hao-Jie Han; Qian Xu; Shuang-Ke Bai展开收起
作者单位
1. ᵃGraduate School, Hebei North University, Zhangjiakou, China; 2. ᵇDepartment of Intensive Medicine, Kailuan General Hospital, Tangshan, China展开收起
66
天
Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage
作者
Arne Gessner; Dennis Kannenkeril; Agnes Bosch; Joanna M. Harazny; Martin F. Fromm; Hannah Klinkhammer; Christian Staerk; Andreas Mayr; Roland E. Schmieder; Renke Maas展开收起
作者单位
1. Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 2. FAU NeW–Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 3. Department of Nephrology and Hypertension, University Hospital, Erlangen, Germany; 4. Department of Human Physiology and Pathophysiology, University of Warmia and Mazury, Olsztyn, Poland; 5. Institute for Medical Biometry and Statistics, Marburg University, Marburg, Germany; 6. IUF–Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany; 7. Department of Statistics, TU Dortmund University, Dortmund, Germany展开收起
42
天
Lipoprotein(a), insulin resistance, and cardiovascular outcomes in metabolic dysfunction-associated steatotic liver disease
作者
Bingtian Dong; Yuping Chen; Fang He; Biao Li; Biao Wu; Zhengdong Chen; Enfa Zhao; Yongjian Chen; Chaoxue Zhang展开收起
作者单位
1. Department of Ultrasound, The First Affiliated Hospital of Anhui Medical University, Hefei, China; 2. Liver Disease Center of Integrated Traditional Chinese and Western Medicine, Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology (Southeast University), Nanjing, China; 3. State Key Laboratory of Digital Medical Engineering, Basic Medicine Research and Innovation Center of Ministry of Education, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China; 4. Department of Cardiology, Chenggong Hospital, Xiamen University, Xiamen, China; 5. Department of Ultrasound, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China; 6. Department of Nephrology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China; 7. Kuanren Laboratory of Translational Lipidology, Centre for Lipid Research, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China; 8. Department of Ultrasound, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天